$20.03
0.834.32%
At close: May 19, 5:00 PM EST
$20.03
0.834.32%
Pre-Market: 4:23 AM EST
Castle Biosciences Inc Stock Guidance
CSTLNASDAQ
Castle Biosciences (CSTL) last issued guidance on May 6, 2026 for fiscal year 2026. The company guided revenue in the range of $345.00M - $355.00M for the period.
Compared to prior guidance, Castle Biosciences raised its revenue forecast from a prior range of $340.00M - $350.00M.
Castle Biosciences has issued 17 guidance updates between August 8, 2022 and May 6, 2026. During this period, the company raised its outlook 12 times and lowered it 1 time, providing investors with insight into management's evolving expectations.
Latest Guidance Date
May 6, 2026
Guidance Period
Full Year 2026
Revenue Guidance Range
$345.00M - $355.00M
Castle Biosciences Guidance History
Review all historical guidance issued by Castle Biosciences, including EPS and revenue forecasts across quarterly and annual periods.
Loading calendar...
FAQ
What is the most recent guidance for Castle Biosciences (CSTL)?
The most recent guidance for Castle Biosciences (CSTL) was reported on May 6, 2026 for the fiscal year 2026. Castle Biosciences forecasted revenue between $345.00M and $355.00M for the period.
What revenue range did Castle Biosciences (CSTL) guide for?
Castle Biosciences (CSTL) guided revenue in the range of $345.00M to $355.00M for the fiscal year 2026.
Did Castle Biosciences (CSTL) raise or lower guidance?
Castle Biosciences (CSTL) raised its revenue guidance from a prior range of $340.00M - $350.00M to $345.00M - $355.00M for the fiscal year 2026.
When did Castle Biosciences (CSTL) last issue guidance?
Castle Biosciences (CSTL) last issued guidance on May 6, 2026 for the fiscal year 2026.
